MENU
CLOSE
Home
News
2019 Announcements
Page 4
2019 Announcements
Filters:
Category
Latest
2016 Announcements
2017 Announcements
2018 Announcements
2019 Announcements
2020 Announcements
2021 Announcements
2022 Announcements
2023 Announcements
2024 Announcements
Clinical
Corporate
Financial
News
Newsletter
Pages
Presentation
Recruitment
Regulatory
Stories
Change in Composition of Audit & Risk Committee
2019 Announcements
25.07.2019
CLINUVEL Newsletter – July 2019
2019 Announcements
11.07.2019
CLINUVEL Relocates Melbourne Office
2019 Announcements
21.06.2019
CLINUVEL INCLUDED IN S&P/ASX 200 INDEX
2019 Announcements
14.06.2019
Presentation Jefferies Healthcare Conference
2019 Announcements
07.06.2019
Lapse and forfeit of Unlisted Conditional Performance Rights
2019 Announcements
05.06.2019
Media Release – US FDA review for SCENESSE® extended 3 months
2019 Announcements
03.06.2019
US FDA extends PDUFA date for SCENESSE®
2019 Announcements
03.06.2019
Change of Director’s Interest Notice
2019 Announcements
15.05.2019
Becoming a substantial holder
2019 Announcements
08.05.2019
CLINUVEL Newsletter
2019 Announcements
02.05.2019
Appendix 4C
2019 Announcements
30.04.2019
Chair Letter to Shareholders
2019 Announcements
24.04.2019
.
‹
1
2
3
4
5
6
›
About
About CLINUVEL
People
Corporate Governance
Photomedicine Foundation
Annual Reports
Pharmaceuticals
About Pharmaceuticals
The Science
Disease Entities
Products
PhotoCosmetics
About PhotoCosmetics
Polychromatic Photoprotection
DNA Repair
Melanogenesis
Investors
Investors Information
ASX Announcements
Analyst Coverage
Media Coverage
Company Snapshot
Financial Summary
Shareholder Information
Investor Enquiry
News
Contact
Store
Go To Top